{
  "report_rows": [
    {
      "kpi": "Non-GAAP diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$4.60 vs. cons ~$4.35",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$1.52B vs. cons ~$1.498B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EBITDA margin",
      "prediction": "IN-LINE",
      "answer": "pred ~21.3% vs. cons ~21.0%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY26 non-GAAP EPS (raise #3?)",
      "prediction": "BETTER",
      "answer": "guide ~$18.90 vs. cons ~$18.60 (FY26)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3'26 revenue guide",
      "prediction": "BETTER",
      "answer": "guide ~$1.52B vs. cons ~$1.50B (Q3'26)",
      "confidence": "LOW"
    },
    {
      "kpi": "Memory/DRAM margin mitigation commentary",
      "prediction": "UNCHANGED",
      "answer": "reaffirm ~2pt GM headwind fully offset, ~22% FY EBITDA margin vs. cons ~22% (FY26 H2)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic revenue growth",
      "prediction": "BETTER",
      "answer": "pred ~5% vs. cons ~4% (Q2'26)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 2.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": 0.5,
  "day5_path": "FADE",
  "day5_rationale": "Beat-and-raise likely delivers a modest initial pop, but the stock already ran ~11% into the print (264->293) with consensus only at the guide midpoint, so much is discounted. Out-period math is the drag: memory/DRAM costs step up sequentially in Q2 and the back half, so even a headline FY EPS raise embeds a richer H2 mitigation burden and un-confirmed supply allocation. That caps upside revisions and invites profit-taking, so the day-1 gain partly fades over the week.",
  "day5_confidence": "LOW"
}